The latest research on genital warts offers hope for HPV prevention in women. In June of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).
The vaccine, called Gardasil, is a product of the latest research on genital warts and can protect against four HPV types, which together cause 70 percent of cervical cancer and 90 percent of genital warts.
Because of this latest research on genital warts, the Food and Drug Administration (FDA) recently licensed this vaccine for use in girls and women from nine to 26 years of age. The vaccine is given through a series of three shots over a six month period.
It is not yet known if the vaccine is effective in boys and men, according to the latest research. It is possible that vaccinating males will have health benefits for them by preventing genital warts and rare cancers, such as penile and anal cancer. It is also possible that vaccinating boys/men will have indirect health benefits for girls/women. Studies are now being conducted to determine if the vaccine works to prevent HPV infection and disease in males. The latest research on genital warts indicates that this concept should be explored.
The latest research on genital warts has shown the vaccine to be very effective. The vaccine was less effective in young women who had already been exposed to one of the HPV types covered by the vaccine.
It is still not known how long the protection provided by the vaccine will last. The latest research shows that have women who got the vaccination five years ago are still protected. More research is being conducted to find out how long protection will last and if a booster vaccine is needed years later.
The FDA has licensed the HPV vaccine as safe and effective in preventing genital warts. The vaccine was tested in over 11,000 females (9-26) around the world. The latest research has shown no serious side effects.
GlossaryGardasil: A new vaccine that has been approved by the FDA for the prevention of HPV in women.
|TreatGenitalWarts.org recommends Homeopathic Treatment to treat your Genital Warts.|